PlainRecalls
FDA Drug Critical Class I Ongoing

Montelukast Sodium Tablets 10 mg, 30-count bottle, Rx Only, By: Hetero Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, Manfuactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, NDC 31722-726-30

Reported: October 3, 2018 Initiated: August 15, 2018 #D-0081-2019

Product Description

Montelukast Sodium Tablets 10 mg, 30-count bottle, Rx Only, By: Hetero Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, Manfuactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, NDC 31722-726-30

Reason for Recall

Labeling: Label Mix-Up - One lot labeled Montelukast Sodium Tablets 10 mg tablets may contain 90 tablets of Losartan Potassium 50 mg.

Details

Units Affected
98016 bottles
Distribution
U.S.A. Nationwide
Location
Jadcherla Mandal, Mahaboob Nagar

Frequently Asked Questions

What product was recalled?
Montelukast Sodium Tablets 10 mg, 30-count bottle, Rx Only, By: Hetero Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, Manfuactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, NDC 31722-726-30. Recalled by Hetero Labs Limited Unit V. Units affected: 98016 bottles.
Why was this product recalled?
Labeling: Label Mix-Up - One lot labeled Montelukast Sodium Tablets 10 mg tablets may contain 90 tablets of Losartan Potassium 50 mg.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 3, 2018. Severity: Critical. Recall number: D-0081-2019.